Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Leap Therapeutics
Leap Therapeutics
BeiGene pulls out of Leap of faith, letting option on immuno-oncology candidate lapse
Fierce Biotech
Fri, 03/17/23 - 09:55 am
BeiGene
immuno-oncology
Leap Therapeutics
DKN-01
Conditions are ripe for reverse mergers
EP Vantage
Fri, 02/24/23 - 08:48 am
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
A trio of biotechs consolidate as M&A fails to materialize at JPM
Fierce Biotech
Tue, 01/17/23 - 11:02 pm
JPMHC 2023
M&A
Leap Therapeutics
Flame Biosciences
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
FDA fast-tracks Leap’s gastric cancer immunotherapy
Pharmaforum
Fri, 09/25/20 - 10:34 am
Leap Therapeutics
FDA
DKN-01
priority review
gastric cancer
Leap zeroes in on subgroup for DKN-01, Keytruda combo
BioCentury
Wed, 08/7/19 - 11:32 pm
Leap Therapeutics
DKN-01
Keytruda
gastric cancer
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518
Business Insider
Mon, 07/23/18 - 10:44 pm
Leap Therapeutics
Pfizer
Merck KGaA
TRX518
avelumab
solid tumors
Could Merck and Leap union be the one for Keytruda?
TheStreet.com
Sat, 06/24/17 - 09:28 am
Merck
Leap Therapeutics
Keytruda
antibodies
DKN-01
esophagogastric cancer